Babu Tirin, Mathew Panachiyil George, Sebastian Juny, Dhati Ravi Mandyam
Department of Pharmacy Practice, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Mysuru, Karnataka, 570015, India.
Department of Paediatrics, JSS Medical College and Hospital, JSS Academy of Higher Education & Research, Mysuru, Karnataka, 570015, India.
Int J Pediatr Adolesc Med. 2021 Mar;8(1):35-38. doi: 10.1016/j.ijpam.2020.01.001. Epub 2020 Jan 7.
Each year nearly 10,000 children with thalassaemia major are born in India, but among them, very few are optimally managed mainly in urban regions even though the Government of India has incorporated their care and treatment in the 12th Five-Year Plan. Data on prescribing patterns and drug-related problems (DRPs) in paediatric thalassaemia patients in India are limited.
In this prospective interventional study, the medications prescribed were recorded after reviewing the treatment charts, thalassaemia register, thalassaemia card, nurses' notes, as well as discharge summaries. When DRPs and/or medication errors were identified, the same was discussed with the concerned health care professionals and suitable suggestions were made at the earliest.
Out of the enrolled 54 patients, only 94% (n = 51) of the patients received iron chelation therapy with deferasirox and/or deferiprone, Folic acid tablet was prescribed for 100% of the patients (n = 54). Five percent of patients (n = 3) had undergone splenectomy and was prescribed with amoxicillin prophylactically. There were a total of 16 DRPs and 15 medication errors were identified and suitable measurements were taken to solve these problems.
The prescribing patterns, DRPs and medication errors in transfusion-dependent paediatric thalassaemia patients were discussed in this study. Our study was effective in identifying and solving the DRPs and medication problems that occurred in thalassaemia patients.
印度每年有近10000名重型地中海贫血患儿出生,但即便印度政府已将对他们的护理和治疗纳入第十二个五年计划,其中仍只有极少数在城市地区得到了最佳管理。关于印度小儿地中海贫血患者的处方模式和药物相关问题(DRP)的数据有限。
在这项前瞻性干预研究中,通过查阅治疗图表、地中海贫血登记册、地中海贫血卡片、护士记录以及出院小结来记录所开的药物。当发现DRP和/或用药错误时,会与相关医护人员进行讨论,并尽早提出适当建议。
在纳入研究的54名患者中,只有94%(n = 51)的患者接受了地拉罗司和/或去铁酮的铁螯合治疗,100%的患者(n = 54)都开了叶酸片。5%的患者(n = 3)接受了脾切除术,并预防性地开了阿莫西林。总共发现了16个DRP和15个用药错误,并采取了适当措施来解决这些问题。
本研究讨论了输血依赖型小儿地中海贫血患者的处方模式、DRP和用药错误。我们的研究有效地识别并解决了地中海贫血患者中出现的DRP和用药问题。